Eritrea is one of the developing countries located in the Eastern Sub-Saharan Africa. Eritrea is experiencing a growing cancer problem, but little is presently known on tumor patterns, cancer epidemiology and ethnic or environmental cancer risk factors. A retrospective study was carried out on the cancer incidence in hospitals of Eritrea and Eritrean National Health Laboratory (ENHL) from 2000 to 2010 using data recorded from the Management Information System (MIS) in ENHL that recorded all cancer cases from across the country. The main objectives of this study were to review the current status of knowledge, summarizing local data, as well as to provide the first baseline data on the cancer incidence in Eritrea. This study was carried out retrospectively and quantitatively by collecting, abstracting, analyzing, coding and interpreting of data recorded in MIS at ENHL in the eleven years of study using CanReg5 software. Generally 19,636 numbers of cases were confirmed by cytology and histology recorded at MIS through the year of 2000 to 2010; out of these 9,482 cases were positive for cancer. From the total positive cancer cases, 39.18% were males and 60.82% were females. The age standardized rate for all cancers in Eritrean hospitals and ENHL from 2000 to 2010 both in men and women combined were 20.3 per 100,000.The rate was higher in women 11.2 per 100,000 than men 9.1 per 100,000. In general, it can be concluded from this research that the incidence of cancer in Eritrean hospitals and ENHL were increased annually from 2000 to 2010, especially in females.The trend of the incidence is increasing with age, therefore the gradual aging of the population might increase the number of cancer cases in Eritrea.
Introduction
Cancer is a group of diseases characterised by the uncontrolled growth and spread abnormal cells 1 . Cancer is a major public health problem in most parts of the world. High-quality population-based cancer incidence data have been collected throughout the world since the early 1960s and published periodically in Cancer Incidence in Five Continents (CI5) 2 
.
Overall the age-standardised cancer rate (excluding nonmelanoma skin cancer) is higher in more developed countries.
There were about 268 cases of cancer diagnosed per 100,000 in more developed countries, compared to 148 in less developed countries in 2012. The rate was 1.8 times higher in more developed compared with less developed countries 3, 4 . The reason for the high incidence rates in western countries for some cancers may in part reflects detection practices in screening and imaging techniques, rather than true disease occurrence. Comparing with developed countries information on routine medical records and death certificates is more likely to be incomplete and population estimates are less likely to be accurate in less developed countries, affecting the accuracy of 
Materials and Methods

Cancer study
The study data was collected from the regional and referral hospitals of the nation. Eritrea was divided into six Zobas, each zoba has its own regional referral hospital, community hospitals and health centers. The nation has also 8 national referral hospitals. The cancer data used in the present study was collected from all these hospitals and hence the data represents the national trends in the incidence of cancer in Eritrea.The ENHL that was based in Asmara is the only referral lab throughout the nation that received cancer cases from all the national referral hospitals, zonal referral hospitals and regional hospitals where all pathologic requests and specimens are This quantitative study was carried out retrospectively in the collection, abstracting, analyzing, coding and interpreting of data. An internationally standardized cancer abstract form that has the same format with the CanReg5 software was used to abstract the data 6 . During entry, the data was analyzed using the pre-determined and developed built-in analysis tools of CanReg5 software version 5.00.35build1471. After all data were entered and analyzed, the international classification of disease for oncology 10 (ICD-10) for coding the primary site, histology, behaviour, and grade of diagnosis was given. Demographic data was captured using a format, which was prepared for coding the residence, place of birth, ethnicity (tribe), and hospital facility of diagnosis with other common sociodemographic variables. In order to provide for international comparisons, the collected and abstracted data was converted into the international classification of disease and related health problem (ICD-1O) format
7
. All positive (for any type of cancer) patients of all ages, ethnic groups, gender, types of patients (whether they were drug monitoring or not), all data from alive or dead patients were included in the study. Moreover, all negative cases of cancer and non-Eritrean citizens were excluded from the study.
Population
Eritrean population pyramid (age-sex distribution) for 2005 adopted from United Nations, department of economic and social affairs, population division, International data Base was used as population data set for generating the cancer incidence rate per 100,000 population during the period of 2000-2010
Statistical Methods
The age standardized incidence rate of Eritrean hospitals and ENHL were calculated for all age groups by sex in each of the eleven years of the study. This age-standardized rate (ASRs) was calculated using the world standard population for each From the total positive cases (n= 9482) 6,652 (70.15%) were benign cases and 2,830 (29.85%) were malignant cases.
The incidence of cancers calculated per 100,000 population by age group was generated by the CanReg5 software and is shown in figure 3 and figure 4 for male and female respectively.
The age-standardized rates of the most common ten cancer incidence per 100,000 population are shown in figures 5 and 6 in men and women respectively. The incidence of bone cancer in men was the highest (ASR around 0.8 per 100,000) and the lowest was breast cancer (ASR approx. 0.4 per 100,000). The highest incidence of cancer in females was breast cancer (ASR approx. 2.7 per 100,000) and the lowest incidence was colon cancer (ASR approx. 0.3 each per 100,000).
In this study cancer incidence increases steeply with age, reaching the value of 46.50% and 33.31% in male and female, respectively, in the ≥ 60 year age group (Figure 7) . In this group, the most prevalent cancers were prostate, bone, and connective and soft tissue in males; and breast, cervix uteri, and esophagus in females (Table 1 and 2).
The cancer abstract form used by the global cancer registries together with CanReg5 software was used to extract cancer data from the pathology request form of the Eritrean National Health Laboratory of Eritrea for positive cancer cases.
The main challenge faced during the current study was the process of extracting data from the pathology request form to the standardized abstract form. In some of the pathology request forms of ENHL, important information such as surname, address, birth date, and age was missing. On the top of this, there was also a problem in giving the morphological details of benign cancers. The ICD-10 is organized by behaviour, anatomic site involved (topography), and morphological code.
However, there was no such detailed information in the form.
The above challenges were resolved by using the International Classification of Disease (ICD, 10th revision) codes, and using a differentiating table for benign and malignant cancers based on tissue organs from the pathology book 7, 10, 11 .
Duplication of subjects was another problem the researchers faced throughout the study. Patients with the same first name; middle name, but may or may not have similar cancer in topography/morphology, were given a surname by using the first letter of their middle name. As a result the percentage of duplication was significantly decreased. Meanwhile, 64 patients had duplicated data with the same name and tumour records, for which the latest one data was used. Another two patients were duplicated with the same patient record but with different topography. These patients were considered as patients with multiple tumours and were added to the total number. Therefore the number of the total recorded patients were reduced from 9,548 to 9,482. The total malignant cases were 2,830 (29.85%) and the total benign cases were 6,652 (70.15%). The incidence of cancer in the current study was unevenly distributed as can be seen in Globally, breast and cervical cancers are the most commonly diagnosed malignant cancers in females. Similarly, both breast (cases 432) and cervix uteri (211 cases) cancers were found to be the most commonly diagnosed malignant cancers in females in the current study. In addition, bone, esophagus, ovary, connective and soft tissue, thyroid, skin, rectum, and colon were also commonly diagnosed malignant cancers in females ( Figure   6 ). The most common malignant cancers in males were bone and prostate gland. Moreover, connective and soft tissue, skin, rectum, esophagus, bladder, colon, stomach, eye, and breast were also commonly diagnosed in males ( Figure 5 ).
Similar studies has been conducted in Sudan, the most commonly diagnosed cancer in females were breast (29.3%), cervix uteri (8.2%),leukemia (7.2%), ovary (6.8%),and oesophagus (5.9%) whereas in males the highest was prostate (7.6%), followed by leukemia (7.0%) 12 . Same study of one year trend also conducted with similar incidence in both sexes.
Almost all the most common cancers in Sudan where also commonly diagnosed in the current study except leukemia in both sexes 100,000 population respectively 14 .
The age-standardized rate for all cancers in the current study, both in men and women combined was 20.3 per 100,000.The rate was higher in women with ASR of 11.2 per 100,000 than in men with ASR of 9.1 per 100,000 population. The highest agestandardized incidence rates of cancers in this study in females were breast cancer 2.7, cervix uteri 1.4, esophagus 0.7, bone 0.6 and ovary 0.5 per 100,000 populations respectively ( Figure   6 ). In males the highest age-standardized incidence rates of cancers were bone 0.8, prostate 0.7, connective and soft tissue 0.6, skin 0.6, and rectum 0.5 per 100,000 population respectively ( Figure 5 ).
Data regarding the mortality rates of cancers in the current study was not calculated because there was no cancer registry and follow up of cancer patients. When compared to that of Eastern Africa, the highest incidence rates of cancer in males in the current study were bone, connective and soft tissue, skin, and prostate. However, the highest incidence rates of cancers in Eastern Africa for males were prostate, Kaposi sarcoma and esophagus 14 .
Study that has been conducted in Uganda, shown marked increase in breast and prostate (3.7% and 5.2% annually) respectively 14, 16 . Cancer of cervix also the most frequent cancer of females in Uganda
17
. Similarly, in Ethiopia the highest estimated age standardized incidence rate in males were Colorectum ASR 10.5, Kaposi sarcoma ASR 10.5, Prostate ASR 6.6, and Leukaemia ASR 9.8.
.
The low incidence rate of Kaposi sarcoma in this study can be attributed to the fact that it is related to HIV/AIDS and the prevalence of HIV/AIDS in Eritrea is relatively low and because of availability of antiretroviral drugs in the country 11, 17 . The high incidence rate of bone cancer in the current study needs further epidemiological studies, whereas the incidence rate of prostate cancer in the current study had a similar incidence with that of Eastern Africa. The highest incidence rate was seen in the age group 75 -80, with age standardized incidence rate of 13.1 (Table 1) .
Breast cancer dominates the pattern of cancer incidence for females in the current study as it is the most commonly diagnosed tumour. 2.7 females in every 100,000 living females were diagnosed with breast cancer. When compared to the incidence rate of Eastern Africa, breast cancer has the same projection. The two highest incidences of cancers in the current study were breast cancer followed by Cervix uteri whereas in Eastern Africa they were reversed, but when the incidence compared to estimated ASR in Ethiopia it has shown more or A number of cancers in the present study show overlapping in both sexes. These are bone, connective and soft tissues, skin, rectum, oesophagus, and colon cancers. Besides being the top 6 cancers in both sexes, they are higher in males than in females ( Figure 8 ). Exception is cancer of the oesophagus, where incidence is higher in females than in males. 
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